论下呼吸道感染病原体构成和耐药特点
On the Composition of Pathogens and Drug Resistance Characteristics of Lower Respiratory Tract Infections
DOI: 10.12677/acm.2024.1461828, PDF,   
作者: 刘常川*：延安大学附属医院全科医学科，陕西 延安；李元军：延安市第二人民医院呼吸与结核科，陕西 延安；陈 卓, 王 锐：延安大学附属医院呼吸内科，陕西 延安
关键词: 下呼吸道感染；病原体；构成；耐药特点；Lower Respiratory Tract Infections； Pathogens； Composition； Drug Resistance Characteristics
摘要: 下呼吸道感染非常常见，其病原体主要有病毒、细菌、支原体、衣原体及真菌等，其中细菌感染为主要感染方向。患者感染后将会对其生活质量造成严重影响，因此，为提高治疗效果，保证患者的安全，需要分别掌握下呼吸道感染病原菌的特点及耐药性，同时采取针对性措施，合理使用抗菌药物。本文主要研讨下呼吸道感染病原体构成及耐药特点，所得结论仅供参考。
Abstract: Lower respiratory tract infections are very common, and their pathogens mainly include viruses, bacteria, mycoplasma, chlamydia and fungi, among which bacterial infections are the main direction of infection. Once the patient is sick, it will have a negative impact on the quality of life, therefore, in order to improve the therapeutic effect and ensure the safety of patients, it is necessary to grasp the characteristics of the lower respiratory tract infections and drug resistance, and at the same time, take targeted measures to rationalize the use of antimicrobial drugs. This article mainly discusses the composition and drug resistance characteristics of lower respiratory tract infection pathogens, and the conclusions are for reference only.
文章引用：刘常川, 李元军, 陈卓, 王锐. 论下呼吸道感染病原体构成和耐药特点[J]. 临床医学进展, 2024, 14(6): 690-694. https://doi.org/10.12677/acm.2024.1461828

参考文献

[1] 杨晓娟. 恒温扩增法在下呼吸道感染病原体检测中的价值[J]. 湖北科技学院学报(医学版), 2023, 37(4): 335-338.
[2] Costelloe, C., Metcalfe, C., Lovering, A., Mant, D. and Hay, A.D. (2010) Effect of Antibiotic Prescribing in Primary Care on Antimicrobial Resistance in Individual Patients: Systematic Review and Meta-Analysis. BMJ, 340, c2096. [Google Scholar] [CrossRef] [PubMed]
[3] 徐伟玲, 于少飞. 病原靶向二代测序在下呼吸道感染病原体诊断中应用价值研究进展[J]. 检验医学与临床, 2023, 20(20): 3068-3072.
[4] GBD 2013 Mortality and Causes of Death Collaborators (2013) Global, Regional, and National Age-Sex Specific All-Cause and Cause-Specific Mortality for 240 Causes of Death, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet, 385, 117-171. [Google Scholar] [CrossRef] 
[5] 任燕飞, 张敏, 杨涛, 等. 下呼吸道感染病原体检测方法及相关病原体研究[J]. 中国现代医生, 2022, 60(25): 114-117.
[6] Woodhead, M. (2005) Guidelines for the Management of Adult Lower Respiratory Tract Infections. European Respiratory Journal, 26, 1138-1180. [Google Scholar] [CrossRef] [PubMed]
[7] Bochud, P., Moser, F., Erard, P., Verdon, F., Studer, J., Villard, G., et al. (2001) Community-Acquired Pneumonia. Medicine, 80, 75-87. [Google Scholar] [CrossRef] [PubMed]
[8] Gutiérrez, F., Masiá, M., Rodríguez, J.C., Mirete, C., Soldán, B., Padilla, S., et al. (2005) Epidemiology of Community-Acquired Pneumonia in Adult Patients at the Dawn of the 21st Century: A Prospective Study on the Mediterranean Coast of Spain. Clinical Microbiology and Infection, 11, 788-800. [Google Scholar] [CrossRef] [PubMed]
[9] Capelastegui, A., España, P.P., Bilbao, A., Gamazo, J., Medel, F., Salgado, J., et al. (2012) Etiology of Community-Acquired Pneumonia in a Population-Based Study: Link between Etiology and Patients Characteristics, Process-of-Care, Clinical Evolution and Outcomes. BMC Infectious Diseases, 12, Article No. 134. [Google Scholar] [CrossRef] [PubMed]
[10] Chen, J., Li, X., Wang, W., Jia, Y., Lin, F. and Xu, J. (2019) The Prevalence of Respiratory Pathogens in Adults with Community-Acquired Pneumonia in an Outpatient Cohort. Infection and Drug Resistance, 12, 2335-2341. [Google Scholar] [CrossRef] [PubMed]
[11] Lagerström, F., Bader, M., Foldevi, M., Fredlund, H., Nordin-Olsson, I. and Holmberg, H. (2003) Microbiological Etiology in Clinically Diagnosed Community-Acquired Pneumonia in Primary Care in Örebro, Sweden. Clinical Microbiology and Infection, 9, 645-652. [Google Scholar] [CrossRef] [PubMed]
[12] Almirall, J., Boixeda, R., Bolíbar, I., Bassa, J., Sauca, G., Vidal, J., et al. (2007) Differences in the Etiology of Community-Acquired Pneumonia According to Site of Care: A Population-Based Study. Respiratory Medicine, 101, 2168-2175. [Google Scholar] [CrossRef] [PubMed]
[13] Yin, Y., Zhao, F., Ren, L., Song, S., Liu, Y., Zhang, J., et al. (2012) Evaluation of the Japanese Respiratory Society Guidelines for the Identification of Mycoplasma pneumoniae Pneumonia. Respirology, 17, 1131-1136. [Google Scholar] [CrossRef] [PubMed]
[14] Burk, M., El-Kersh, K., Saad, M., Wiemken, T., Ramirez, J. and Cavallazzi, R. (2016) Viral Infection in Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. European Respiratory Review, 25, 178-188. [Google Scholar] [CrossRef] [PubMed]
[15] 王婷婷, 刘怀燕, 黄家望, 等. 恒温扩增芯片法在下呼吸道感染病原体检测中的应用[J]. 国际检验医学杂志, 2022, 43(8): 916-920.
[16] 王斯丽. 6926例儿童下呼吸道感染病原体检测与分析[J]. 母婴世界, 2020(9): 16-17.
[17] 裴蕴锋, 雷薇, 张岩, 等. LAMP法检测下呼吸道感染与肺癌合并下呼吸道感染病原体特征[J]. 徐州医科大学学报, 2020, 40(10): 730-734.
[18] 周芳. 儿童下呼吸道感染病原体分布及耐药情况研究进展[J]. 贵州医药, 2022, 46(1): 20-22.
[19] Serpa, P.H., Deng, X., Abdelghany, M., Crawford, E., Malcolm, K., Caldera, S., et al. (2022) Metagenomic Prediction of Antimicrobial Resistance in Critically Ill Patients with Lower Respiratory Tract Infections. Genome Medicine, 14, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
[20] 杨增利, 蒋晓东, 陈洁. 恒温扩增法在下呼吸道感染病原体检测的应用[J]. 养生大世界, 2022(22): 201-202.
[21] 俞云松. 超广谱β-内酰胺酶研究进展[J]. 中华医学杂志, 2006, 86(9): 641-644.
[22] 张雪妍. 下呼吸道感染病原菌分布及药敏结果分析[D]: [硕士学位论文]. 长春: 吉林大学, 2020.
[23] 胡付品, 郭燕, 朱德妹, 等. 2021年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2022, 22(5): 521-530. [Google Scholar] [CrossRef] 
[24] 熊莉. 南昌市某呼吸专科医院下呼吸道感染铜绿假单胞菌的耐药特征及影响因素分析[D]: [硕士学位论文]. 南昌: 南昌大学医学部, 2019.

为你推荐